Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3
- PMID: 6694918
- DOI: 10.1002/pros.2990050109
Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3
Abstract
In growth proliferation experiments on two human prostatic carcinoma cell lines, DU 145 cells were found to be more sensitive to the cytotoxic effect of estramustine and nor-nitrogen mustard than PC-3 cells. Estramustine was, however, much more cytotoxic in both cell lines than nor-nitrogen mustard. Cytogenetic experiments revealed that estramustine produced a drastic increase of the mitotic index in both these cell lines. This increase could be accounted for by the arrest of cells in their first treatment-metaphase. The arrested metaphases exhibited all the characteristics commonly found for stathmokinetic agents such as colchicine and vinca-analogues. No mitotic arrest was found for nor-nitrogen mustard but chromosomal aberrations were found at toxic concentrations. Estradiol exhibited minimal toxicity and caused no mitotic arrest in these cell lines. The mitotic arrest induced by estramustine was found to be reversible on removal of the drug.
Similar articles
-
Cytotoxic properties of estramustine unrelated to alkylating and steroid constituents.Urology. 1984 Jun;23(6 Suppl):28-33. doi: 10.1016/s0090-4295(84)80094-1. Urology. 1984. PMID: 6730140
-
Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).J Urol. 1982 Apr;127(4):818-22. doi: 10.1016/s0022-5347(17)54057-4. J Urol. 1982. PMID: 7069864
-
Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.Urol Res. 1987;15(3):155-60. doi: 10.1007/BF00254428. Urol Res. 1987. PMID: 3307087
-
The mechanism of action of estramustine.Semin Oncol. 1983 Sep;10(3 Suppl 3):21-6. Semin Oncol. 1983. PMID: 6364362 Review. No abstract available.
-
Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.Int Urol Nephrol. 1989;21(4):393-7. doi: 10.1007/BF02559635. Int Urol Nephrol. 1989. PMID: 2693392 Review.
Cited by
-
Impairment of estramustine phosphate absorption by concurrent intake of milk and food.Eur J Clin Pharmacol. 1990;38(2):189-93. doi: 10.1007/BF00265983. Eur J Clin Pharmacol. 1990. PMID: 2338118 Clinical Trial.
-
Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.Br J Cancer. 1991 Aug;64(2):267-73. doi: 10.1038/bjc.1991.290. Br J Cancer. 1991. PMID: 1892755 Free PMC article.
-
Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro.J Cancer Res Clin Oncol. 1991;117(3):244-8. doi: 10.1007/BF01625432. J Cancer Res Clin Oncol. 1991. PMID: 2033092 Free PMC article.
-
Accumulation of estramustine and estromustine in adipose tissue of rats and humans.Cancer Chemother Pharmacol. 1991;28(5):361-4. doi: 10.1007/BF00685690. Cancer Chemother Pharmacol. 1991. PMID: 1914079
-
Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.Br J Cancer. 1997;76(3):318-24. doi: 10.1038/bjc.1997.385. Br J Cancer. 1997. PMID: 9252198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical